Literature DB >> 11474877

Phenotypic and genotypic study of Streptococcus agalactiae in vagina of pregnant women in Argentina.

I Toresani1, A Limansky, I Bogado, M C Guardati, A Viale, E G Sutich.   

Abstract

Streptococcus agalactiae (GBS) is a leading cause of serious neonatal infection. In this study we determine the prevalence, serotype distribution and genomic diversity of GBS in vagina of pregnant women. Vaginal swabs of 531 pregnant women were cultured on Columbia Agar Base Blood, GBS Agar Base and Todd Hewitt Broth. GBS were characterized by group and type-specific agglutination. Genomic polymorphism was studied by random amplification of DNA (RAPD). Seventeen patients (3.2%) were positive for GBS, resulting serotype III the most frequent. RAPD detected 16 different RAPD profiles from 21 GBS studied, revealing a good discriminatory power. In this sense, this method showed different genotype from GBS serotype III recovered from successive samples of two patients, suggesting reinfection. In conclusion, the combination of RAPD and serotyping appear promising for epidemiological studies. Finally, findings of reinfection after therapy during pregnancy, led us to suggest performing prenatal GBS screening and intrapartum prophylaxis in order to reduce neonatal risk.

Entities:  

Mesh:

Year:  2001        PMID: 11474877

Source DB:  PubMed          Journal:  Medicina (B Aires)        ISSN: 0025-7680            Impact factor:   0.653


  8 in total

Review 1.  Perinatal Streptococcus agalactiae Epidemiology and Surveillance Targets.

Authors:  Lucy L Furfaro; Barbara J Chang; Matthew S Payne
Journal:  Clin Microbiol Rev       Date:  2018-08-15       Impact factor: 26.132

Review 2.  Molecular epidemiology of group B streptococcal infections.

Authors:  E Tkacikova; I Mikula; A Dmitriev
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

3.  Group B streptococcus serotype prevalence in reproductive-age women at a tertiary care military medical center relative to global serotype distribution.

Authors:  Danielle L Ippolito; Wesley A James; Deborah Tinnemore; Raywin R Huang; Mary J Dehart; Julie Williams; Mark A Wingerd; Samandra T Demons
Journal:  BMC Infect Dis       Date:  2010-11-24       Impact factor: 3.090

4.  Prevalence, serotypes and virulence genes of Streptococcus agalactiae isolated from pregnant women with 35-37 weeks of gestation.

Authors:  Fernando J Bobadilla; Marina G Novosak; Iliana J Cortese; Osvaldo D Delgado; Margarita E Laczeski
Journal:  BMC Infect Dis       Date:  2021-01-14       Impact factor: 3.090

5.  Genotyping of Streptococcus agalactiae (group B streptococci) isolated from vaginal and rectal swabs of women at 35-37 weeks of pregnancy.

Authors:  Nabil Abdullah El Aila; Inge Tency; Geert Claeys; Bart Saerens; Ellen De Backer; Marleen Temmerman; Rita Verhelst; Mario Vaneechoutte
Journal:  BMC Infect Dis       Date:  2009-09-11       Impact factor: 3.090

6.  Epidemiology and aetiology of maternal bacterial and viral infections in low- and middle-income countries.

Authors:  Prasad Palani Velu; Courtney A Gravett; Tom K Roberts; Thor A Wagner; Jian Shayne F Zhang; Craig E Rubens; Michael G Gravett; Harry Campbell; Igor Rudan
Journal:  J Glob Health       Date:  2011-12       Impact factor: 4.413

7.  Antibiotic susceptibility patterns and prevalence of group B Streptococcus isolated from pregnant women in Misiones, Argentina.

Authors:  M Quiroga; E Pegels; P Oviedo; E Pereyra; M Vergara
Journal:  Braz J Microbiol       Date:  2008-06-01       Impact factor: 2.476

8.  Evaluation of chromID strepto B as a screening media for Streptococcus agalactiae.

Authors:  Toyohisa Morita; Dongyun Feng; Yoko Kamio; Isao Kanno; Teruo Somaya; Kazuhito Imai; Misaki Inoue; Mutsunori Fujiwara; Akihito Miyauchi
Journal:  BMC Infect Dis       Date:  2014-01-29       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.